The EWS-WT1 translocation product induces PDGFA in desmoplastic small round-cell tumour

Nature Genetics

Volumn 17, Issue 3, 1997, Pages 309-313

  Lee Bong, Sean ^a   Kolquist, Kathryn Ann ^b   Nichols, Kim ^a   Englert, Christoph ^a   Maheswaran, Shyamala ^a   Ladanyi, Marc ^b   Gerald, William L ^b   Haber, Daniel A ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLATELET DERIVED GROWTH FACTOR; TRANSCRIPTION FACTOR;

ARTICLE; CHIMERA; CHROMOSOME TRANSLOCATION 11; CHROMOSOME TRANSLOCATION 22; CONTROLLED STUDY; EWING SARCOMA; GENE ISOLATION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; MALIGNANT TRANSFORMATION; NEPHROBLASTOMA; PRIORITY JOURNAL; REPRESSOR GENE; SUPPRESSOR GENE;

BINDING SITES; BLOTTING, NORTHERN; DNA-BINDING PROTEINS; EARLY GROWTH RESPONSE PROTEIN 1; GENE EXPRESSION REGULATION, NEOPLASTIC; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS; HUMANS; IMMEDIATE-EARLY PROTEINS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; ONCOGENE PROTEINS, FUSION; OSTEOSARCOMA; PLATELET-DERIVED GROWTH FACTOR; PROMOTER REGIONS (GENETICS); RECOMBINANT PROTEINS; RIBONUCLEOPROTEINS; RNA-BINDING PROTEIN EWS; TETRACYCLINE; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSLOCATION, GENETIC; TUMOR CELLS, CULTURED;

CHIMAERA;

EID: 0030699247     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/ng1197-309     Document Type: Article

References (31)

1. Gerald, W.L. et al. Intra-abdominal desmoplastic small round-cell tumor. Am. J. Surg. Pathol. 15, 499-513 (1991).
2. Ladanyi, M. & Gerald, W. Fusion of the EW5 and WT1 genes in the desmoplastic small round cell tumor. Cancer Res. 54, 2837-2840 (1994).
3. Gerald, W.L., Rosai, J. & Ladanyi, M. Characterization of the genomic breakpoint and chimeric transcripts in the EWS-WT1 gene fusion in desmoplastic small round cell tumor. Proc. Natl. Acad. Sci. USA 92, 1028-1032 (1995).
4. Rauscher, F.J., III. The WT1 Wilms tumor gene product: a developmentally regulated transcription factor in the kidney that functions as a tumor suppressor. FASEB J. 7, 896-903 (1993).
5. Wang, Z., Madden, S., Deuel, T. & Rauscher, F., III. The Wilms' tumor gene product, WT1, represses transcription of the platelet-derived growth factor A-chain gene. J. Biol. Chem. 267, 21999-22002 (1992).
6. Gashler, A. et al. Human platelet-derived growth factor A chain is transcriptionally repressed by the Wilms' tumor suppressor WT1. Proc. Natl. Acad. Sci. USA 89, 10984-10988 (1992).
7. Delattre, O. et al. Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature 359, 162-165 (1992).
8. Crozat, A., Aman, P., Mandahl, N. & Ron, D. Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma. Nature 363, 640-644 (1993).
9. Zucman, J. et al. Combinatorial generation of variable fusion proteins in the Ewing family of tumours. EMBO J. 12, 4481-4487 (1993).
10. Zucman, J. et al. EWS and ATF-1 gene fusion induced by t(12;22) translocation in malignant melanoma of soft parts. Nature Genet. 4, 341-345 (1993).
11. Sorensen, P.H.B. et al. A second Ewing's sarcoma translocation, t(21;22), fuses the EWSgene to another ETS-family transcription factor, ERG. Nature Genet 6, 146-151 (1994).
12. Englert, C. et al. WT1 suppresses synthesis of the epidermal growth factor receptor and induces apoptosis. EMBO J. 14, 4662-4675 (1995).
13. Zinszner, H., Immanuel, D., Yin, Y., Liang, F.-X. & Ron, D. A topogenic role for the oncogenic N-terminus of TLS: nucleolar localization when transcription is inhibited. Oncogens 14, 451-461 (1997).
14. Larsson, D.H. et al. Subnuclear localization of WT1 in splicing or transcription factor domains is regulated by alternative splicing. Cell 81, 391-401 (1995).
15. Englert, C. et al. Truncated WT1 mutants alter the subnuclear localization of the wild-type protein. Proc. Natl. Acad. Sci. USA 92, 11960-11964 (1995).
16. May, W.A. et al. The Ewing's sarcoma EWS/Fli-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than Fli-1. Mol. Cell. Biol. 13, 7393-7398 (1993).
17. Haber, D.A. et al. WT1-mediated growth suppression of Wilms tumor cells expressing a WT1 splicing variant. Science 262, 2057-2059 (1993).
18. Werner, H. et al. Increased expression of the insulin-like growth factor I receptor gene IGF1R in Wilms tumor is correlated with modulation of IGF1R promoter activity by the WT1 Wilms tumor gene product. Proc. Natl. Acad. Sci. USA 90, 5828-5832 (1993).
19. Werner, H. et al. Transcriptional repression of the insulin-like growth factor I receptor (IGF-I-R) gene by the tumor suppressor WT1 involves binding to sequences both upstream and downstream of the IGF-I-R gene transcription start site. J. Biol. Chem. 269, 12577-12582 (1994).
20. Takimoto, Y., Wang, Z.Y., Kobler, K. & Deuel, T.F. Promoter region of the human platelet-derived growth factor A-chain gene. Proc. Natl. Acad. Sci. USA 88, 1686-1690 (1991).
21. Rorsman, F., Leveen, P. & Betsholtz, C. Platelet-derived growth factor (PDGF) A-chain mRNA heterogeneity generated by the use of alternative promoters and alternative polyadenylation sites. Growth Factors 7, 241-251 (1992).
22. Wang, Z., Qiu, Q., Enger, K. & Deuel, T. A second transcriptionally active DNA-binding site for the Wilms tumor gene product, WT1. Proc. Natl. Acad. Sci. USA 90, 8896-8900 (1993).
23. Reddy, J., Hosono, S. & Licht, J. The transcriptional effect of WT1 is modulated by choice of expression vector. J. Biol. Chem. 270, 29976-29982 (1995).
24. Heldin, C.-H. Structural and functional studies on platelet-derived growth factor. EMBO J. 11, 4251-4259 (1992).
25. Seppa, H.E., Grotendorst, G.R., Seppa, S.I., Schiffman, E. & Martin, G.R. Platelet-derived growth factor is chemotactic for fibroblasts. J. Cell Biol. 92, 584-588 (1982).
26. Vignaud, J.M. et al. The role of platelet-derived growth factor production by tumor-associated macrophages in tumor stroma formation in lung cancer. Cancer Res. 54, 5455-5463 (1994).
27. Anan, K. et al. Vascular endothelial growth factor and platelet-derived growth factor are potential angiogenic and metastatic factors in human breast cancer. Surgery 119, 333-339 (1996).
28. Eming, S.A. et al. Genetically modified human epidermis overexpressing PDGF-A directs the development of a cellular and vascular connective tissue stroma when transplanted to athymic mice-implications for the use of genetically modified keratinocytes to modulate dermal regeneration. J. Invest. Dermatol. 105, 756-763 (1995).
29. Cleary, M.L. Oncogenic conversion of transcription factors by chromosomal translocations. Cell 66, 619-622 (1991).
30. Rabbitts, T.H. Chromosomal translocations in human cancer. Nature 372, 143-149 (1994).
31. Braun, B.S., Frieden, R., Lessnick, S.L., May, W.A. & Denny, C.T. Identification of target genes for the Ewing's sarcoma EWS/Fli fusion protein by representational difference analysis. Mol. Cell. Biol. 15, 4623-1630 (1995).